missing a dose of semaglutide Missed Dose: What Providers Recommend – PlexusDx Missed Semaglutide Dose: What Happens

FDA-approved GLP-1 treatments for type 2 diabetes and obesity include semaglutide (Ozempic) and tirzepatide (Mounjaro) (FDA 2025)

E.WallinB

Cigna will stop covering GLP-1 weight-loss drugs such as Wegovy and Zepbound for its employees starting July 1, signaling that even major healthcare companies are struggling with the high cost of these medications

Global economic instability, trade tensions, and geopolitical conflicts can disrupt supply chains, restrict cross-border investments, and hinder regulatory approvals

Its used to treat type 2 diabetes and has also shown benefits for people looking to improve weight and overall metabolic health